To determine the volume of bronchoalveolar lavage (BAL) fluid necessary to diagnose Pneumocystis carinii pneumonia (PCP) in immunocompromised patients, specimens from 25 patients were evaluated. Twenty-one patients were HIV infected. BAL was performed using three to four 60-mL aliquots of room temperature, sterile, saline solution. Each syringe of BAL effluent was numbered and its volume was measured. Immunofluorescent stains were performed on about 8-mL aliquots of the initial, final, and aggregate BAL specimens, and a modified Giemsa stain was also performed on a 0.4-mL aliquot of the aggregate specimen. Of 25 patients, Pneumocystis carinii organisms were identified in 9 with HIV infection, in whom all BAL specimens were positive with both immunofluorescence and Giemsa
The development of fever, dyspnea, and new pulmonary infiltrates in immunosuppressed patients is often associated with life-threatening infection.1 Pneumocystis carinii pneumonia (PCP) is a frequent cause of infection in immunocompromised patients with deficient cell-mediated immune responses such as those with the AIDS.' Because of the broad differential diagnosis and the difficulty establishing a microbiologic diagnosis of lower respiratory tract infection from sputum evaluations or blood cultures, fiberoptic bronchoscopy (FB) is commonly performed. 2 Of the specimens that can be obtained through the bronchoscope, bronchoalveolar lavage (BAL) provides a relatively safe and atraumatic method of sampling the alveolar spaces. 3 In 1990, the BAL Cooperative Group Steering Committee reported BAL results from normal volunteers and selected abnormal patients (smokers, those with idiopathic pulmonary fibrosis and connective tissue disease, and asbestos-exposed and silica-exposed individuals), who underwent lavage using 240 mL of of clinical instability. After each procedure, the FB was thoroughly cleaned in a procedure that included detergent brushing and rinsing to remove mucus followed by a 20-min soak in 2% glutaraldehyde solution.
BAL effluent specimens were numbered one to four and the volume of each specimen was measured. BAL specimens were processed for P carinii organisms (trophozoites and cysts) using the method recommended by Gill et al. 5 An aliquot of 5 to 8 mL was centrifuged at 2,500 rpm for 5 min using a refrigerated centrifuge (Jovan GR [4] [5] [6] [7] [8] [9] [10] [11] [12] In the 21 patients who underwent lavage with 240 mL of saline solution, the mean volume of lavage effluent was 113 mL (range, 11 to 175 mL) ( Table 3) . Four patients underwent lavage with 180 mL, mean effluent volume was 76 mL (range, 55 to 100 mL).
DISCUSSION
In this study, deficient cell-mediated immunity predisposed 24 of 25 individuals (HIV disease, 21; and chronic lymphocytic leukemia, 3) to PCP. Although all patients had symptoms and signs of lower respiratory tract infection and 23 of 25 had abnormal chest radiographs, most were not severely hypoxemic. Room air arterial blood gas values showed Po2 values below 65 mm Hg in only 4 of 18 patients (the 7 other patients were receiving supplemental oxygen when arterial blood gas measurements were performed). The infrequency of severe hypoxemia in this group of patients may have resulted from their frequent outpatient evaluations and the early assessment of symptoms of pulmonary infections.
Our patients underwent bronchoscopy with BAL after evaluation of sputum, blood, and other specimens failed to diagnose the organism(s) responsible for their pneumonias. Although some investigators have reported a high diagnostic yield for P carinii from induced sputum,1 results at our institution have been poor. We therefore proceeded quickly to BAL, an approach reported to be more cost effective for diagnosing PCP than sputum induction.6
In 1990, the American Thoracic Society BAL Cooperative Group Steering Committee recommended that BAL be performed with 240 mL of saline solution (four 60-mL aliquots).4 By using this BAL volume, investigators could better compare their patients with the 191 individuals described in the Steering Committee report.4 We realize that this recommendation was generated from a study of normal volunteers, asymptomatic smokers, and patients with various interstitial lung diseases, rather than from patients with lower respiratory tract infections. After publication of the report, however, we had modified our institution's BAL procedure to apply to all patients undergoing this procedure.
We were concerned that large-volume (240 mL) BAL could adversely affect patients' respiratory status, as we have commonly observed transient desaturation during this procedure, especially in patients with bilateral pulmonary infiltrates. In fact, Verra In contrast to the Steering Committee recommendations, a subsequent official American Thoracic Society statement on the clinical role of BAL in adults with pulmonary diseases stated that "although use of volumes as great as 400 mL have been reported, usually the total volume used per site is 100 to 150 mL infused in about 50-to 60-mL aliquots.7'3 Our survey of published reports of patients with AIDS with pulmonary infections revealed no standardization of the BAL procedure. Stover et a18 did not report their BAL method in 35 patients with PCP. Golden et a19 and Broaddus et al,10 reporting from the same medical center, used 20-mL lavage boluses for a total volume of up to 120 mL. Weldon-Linne et al"I instilled 100 to 150 mL "in small aliquots." Using 20-mL aliquots, Yung et al12 suctioned after each infusion, until a 25-mL specimen trap was filled; however, they evaluated two different lobes and the total volume of lavage fluid infused was not reported. Levine et all3 used 35-mL aliquots from one to two lobes, but the total volume did not exceed 150 mL. Verra et a17 used four 50-mL aliquots. Jules-Elysee et all4 performed lavage on both lungs with 60 to 150 mL on each side; they did not specify the aliquot volume.
Since the optimal volume for BAL is unknown, we reasoned that if small volume BAL could successfully diagnose the microbacteriologic agent(s) responsible for lower respiratory tract infection, the safety of the procedure might be improved. Our data show that a single aliquot, 60-mL BAL yields an effluent volume of 15 to 25 mL. When a 5-to 8-mL aliquot is processed, stained, and examined with immunofluorescence microscopy using the method of Gill et al,5 P carinii organisms will be diagnosed with 100% specificity (95% CI, 83 to 100%) and 100% sensitivity (95% CI, 72 to 100%), and at least half of the specimen will be available for additional microbiologic or cytologic testing. Although it is possible that direct lung tissue biopsy specimens might have revealed PCP in the 16 patients with negative BAL studies, ie, false-negative results, we believe it is unlikely because all patients improved clinically without anti-Pneumocystis therapy. Because we did not perform modified Giemsa staining on first lavage specimens, we cannot state whether this staining technique would have had similar diagnostic accuracy on a single specimen of lavage effluent. We did note, however, that the modified Giemsa technique was accurate in the four patients whose total lavage volume was 180 mL. The excellent sensitivity and specificity of the clinical results in this small study are related to the accuracy of the staining methods; other investigators have reported similarly high yields.13
In summary, using an immunofluorescence staining technique to analyze the fluid returned from the initial 60-mL sample of a 180-to 240-mL BAL, we have shown that P carinii infection was reliably diagnosed in a small group of HIV-infected patients. We believe that low-volume (60 mL) BAL will diagnose PCP reliably and more safely in individuals with significantly compromised respiratory status. Further studies will be required to determine whether low-volume BAL will accurately diagnose the cause of other pneumonias in immunocompromised hosts and whether it will reduce the possibility of postprocedure pulmonary complications.
